ESPE Yearbook of Paediatric Endocrinology

Preface: The increasing prevalence of Type 2 diabetes (T2DM) is well established, and includes new at-risk groups, such as children with attention deficit syndrome. It has become clear that T2DM in adolescents is more aggressive than in adults, and studies by the RISE consortium have clarified the basis of this difference. Treatment with subcutaneous liraglutide holds promise for adolescents with T2DM. Furthermore, this year the FDA approved artificial intelligence to diagnose...